These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
430 related items for PubMed ID: 9398179
41. Viscous drag as the source of active site perturbation during protease translocation: insights into how inhibitory processes are controlled by serpin metastability. Shin JS, Yu MH. J Mol Biol; 2006 Jun 02; 359(2):378-89. PubMed ID: 16626735 [Abstract] [Full Text] [Related]
42. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity. Rezaie AR, Sun MF, Gailani D. Biochemistry; 2006 Aug 08; 45(31):9427-33. PubMed ID: 16878977 [Abstract] [Full Text] [Related]
43. Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases. Aertgeerts K, De Ranter CJ, Booth NA, Declerck PJ. J Struct Biol; 1997 Apr 08; 118(3):236-42. PubMed ID: 9169233 [Abstract] [Full Text] [Related]
47. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase. Whisstock J, Lesk AM, Carrell R. Proteins; 1996 Nov 08; 26(3):288-303. PubMed ID: 8953650 [Abstract] [Full Text] [Related]
48. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases. Qasim MA, Ganz PJ, Saunders CW, Bateman KS, James MN, Laskowski M. Biochemistry; 1997 Feb 18; 36(7):1598-607. PubMed ID: 9048543 [Abstract] [Full Text] [Related]
49. Specificity and reactive loop length requirements for crmA inhibition of serine proteases. Tesch LD, Raghavendra MP, Bedsted-Faarvang T, Gettins PG, Olson ST. Protein Sci; 2005 Feb 18; 14(2):533-42. PubMed ID: 15632287 [Abstract] [Full Text] [Related]
50. Identification of serpin determinants of specificity and selectivity for furin inhibition through studies of α1PDX (α1-protease inhibitor Portland)-serpin B8 and furin active-site loop chimeras. Izaguirre G, Qi L, Lima M, Olson ST. J Biol Chem; 2013 Jul 26; 288(30):21802-14. PubMed ID: 23744066 [Abstract] [Full Text] [Related]
53. Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein. Chen VC, Chao L, Chao J. J Biol Chem; 2000 Dec 08; 275(49):38457-66. PubMed ID: 10993887 [Abstract] [Full Text] [Related]
56. Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. Becerra SP, Sagasti A, Spinella P, Notario V. J Biol Chem; 1995 Oct 27; 270(43):25992-9. PubMed ID: 7592790 [Abstract] [Full Text] [Related]
57. Structural basis of latency in plasminogen activator inhibitor-1. Mottonen J, Strand A, Symersky J, Sweet RM, Danley DE, Geoghegan KF, Gerard RD, Goldsmith EJ. Nature; 1992 Jan 16; 355(6357):270-3. PubMed ID: 1731226 [Abstract] [Full Text] [Related]
58. Heterogeneity in serpin-protease complexes as demonstrated by differences in the mechanism of complex breakdown. Plotnick MI, Samakur M, Wang ZM, Liu X, Rubin H, Schechter NM, Selwood T. Biochemistry; 2002 Jan 08; 41(1):334-42. PubMed ID: 11772033 [Abstract] [Full Text] [Related]